Pharmaceutical

Study links sleep apnea to type 2 diabetes

sleep apnea WIKI Study links sleep apnea to type 2 diabetesPeople who suffer from sleep apnea are more likely to suffer from type 2 diabetes  than people who have a more restful night’s sleep, according to a new study presented at the American Thoracic Society (ATS) 2012 International Conference. Researchers also concluded that low oxygen levels in the blood during sleep hours, a symptom of sleep apnea, is linked to levels of glycosylated hemoglobin (HbA1c), a targeted indicator for diabetes.

Previous studies have linked sleep apnea and sleep disturbances to a higher risk for type 2 diabetes. In 2007, a study from Yale showed the risk of diabetes among people with sleep disorders was as much as two-and-a-half times higher than people with no sleep issues. And, a 2005 study showed treating sleep apnea could help improve blood sugar levels in patients with diabetes.

Earlier this week, a new study from the University of Wisconsin School of Medicine and Public Medicine showed that people with severe sleep apnea were five times more likely to die from cancer than people without sleep apnea.

Type 2 diabetes is often controlled with medications, but many type 2 diabetes medications can be dangerous. In 2010, the Food and Drug Administration (FDA) severely restricted the use of Avandia after studies linked the drug to fatal heart attacks. Soon after, the agency warned consumers that the type 2 diabetes drug Actos had been linked to bladder cancer.

Attorneys at Beasley Allen Law Firm are currently investigating cases of bladder cancer in patients who used Actos.

Source: Huffington Post